Arena Pharmaceuticals Statistics Share Statistics Arena Pharmaceuticals has 0
shares outstanding. The number of shares has increased by 1.59%
in one year.
Shares Outstanding n/a Shares Change (YoY) 1.59% Shares Change (QoQ) 1.59% Owned by Institutions (%) n/a Shares Floating 61.52M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 6.02M, so 0% of the outstanding
shares have been sold short.
Short Interest 6.02M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 7.91
Valuation Ratios The PE ratio is -8.2 and the forward
PE ratio is null.
Arena Pharmaceuticals's PEG ratio is
-0.15.
PE Ratio -8.2 Forward PE n/a PS Ratio 94260.09 Forward PS n/a PB Ratio 7.56 P/FCF Ratio -9.73 PEG Ratio -0.15
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Arena Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 8.59,
with a Debt / Equity ratio of 0.06.
Current Ratio 8.59 Quick Ratio 8.59 Debt / Equity 0.06 Debt / EBITDA -0.07 Debt / FCF -0.08 Interest Coverage -147.22
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $120.54 Profits Per Employee $-1.39M Employee Count 448 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 4.16M Effective Tax Rate -0.67%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.55, so Arena Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.55 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) 79.03 Average Volume (20 Days) 1,472,638
Income Statement In the last 12 months, Arena Pharmaceuticals had revenue of 54K
and earned -620.59M
in profits. Earnings per share was -11.33.
Revenue 54K Gross Profit 54K Operating Income -612.27M Net Income -620.59M EBITDA -608.4M EBIT -612.27M Earnings Per Share (EPS) -11.33
Full Income Statement Balance Sheet The company has 224.57M in cash and 41.21M in
debt, giving a net cash position of 183.36M.
Cash & Cash Equivalents 224.57M Total Debt 41.21M Net Cash 183.36M Retained Earnings -2.12B Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -452.02M
and capital expenditures -70.99M, giving a free cash flow of -523M.
Operating Cash Flow -452.02M Capital Expenditures -70.99M Free Cash Flow -523M FCF Per Share -9.55
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -1133840.74% and -1149244.44%.
Gross Margin 100% Operating Margin -1133840.74% Pretax Margin -1141542.59% Profit Margin -1149244.44% EBITDA Margin -1126670.37% EBIT Margin -1133840.74% FCF Margin -968525.93%
Dividends & Yields ARNA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ARNA.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 19, 2017. It was a
backward
split with a ratio of 1:10.
Last Split Date Jun 19, 2017 Split Type backward Split Ratio 1:10
Scores Altman Z-Score n/a Piotroski F-Score n/a
